S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/Adar1 Capital Management/Q3 2024

Adar1 Capital Management

Period: Q3 2024 Β· Filed: 2024-11-14
View on SEC EDGAR β†—
AUM
$610M
Total portfolio value
Positions
278
Reported securities
Top Holding
CYTK
7.8% $48.1M
QoQ Changes
+8 / -8
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2024-11-14) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
CYTKCYTOKINETICS INC$48.1M7.82%$52.80$86.49+63.8%
7.8%
PTGXPROTAGONIST THERAPEUTICS INC$44.2M7.18%$45.00$131.62+192.5%
7.2%
BBIOBRIDGEBIO PHARMA INC$36.9M6.00%$25.46$77.19+203.2%
6.0%
BOXXEA SERIES TRUST$35.2M5.73%$108.93$117.22+7.6%
5.7%
ROIVROIVANT SCIENCES LTD$34.9M5.68%$11.54$35.13+204.4%
5.7%
IMVTIMMUNOVANT INC$32.3M5.25%$28.51$38.79+36.1%
5.3%
RPRXROYALTY PHARMA PLC$31.0M5.05%$27.11$57.77+113.1%
5.0%
KROSKEROS THERAPEUTICS INC$25.9M4.20%$58.07$11.26-80.6%
4.2%
ASNDASCENDIS PHARMA A/S$24.1M3.92%$149.31$274.50+83.8%
3.9%
ZURAZURA BIO LTD$15.3M2.49%$4.06$5.17+27.3%
2.5%
ZLABZAI LAB LTD$12.8M2.09%$24.14$19.12-20.8%
2.1%
KNSAKINIKSA PHARMACEUTICALS INTL$10.9M1.77%$24.99$64.53+158.2%
1.8%
AAMAA MISSION ACQUISITION CORP$10.1M1.65%β€”β€”
1.6%
MLYSMINERALYS THERAPEUTICS INC$8.8M1.44%$12.11$27.69+128.7%
1.4%
ABUSARBUTUS BIOPHARMA CORP$8.0M1.31%$3.85$4.87+26.5%
1.3%
SLDBSOLID BIOSCIENCES INC$8.0M1.30%$6.97$10.84+55.5%
1.3%
MRUSMERUS N V$7.7M1.25%β€”β€”
1.3%
RZLTREZOLUTE INC$7.6M1.24%$4.85$4.91+1.2%
1.2%
PCSCPERCEPTIVE CAP SOLUTIONS COR$7.5M1.22%$10.02$11.00+9.8%
1.2%
XNCRXENCOR INC$6.9M1.12%$20.11$15.00-25.4%
1.1%
SNDXSYNDAX PHARMACEUTICALS INC$6.7M1.10%$19.25$21.82+13.3%
1.1%
ANABANAPTYSBIO INC$6.5M1.05%$22.33$63.42+184.0%
1.1%
ABVXABIVAX SA$6.0M0.98%$11.52$144.65+1155.6%
1.0%
RGNXREGENXBIO INC$6.0M0.97%$10.49$13.28+26.6%
1.0%
BIIBBIOGEN INC$5.7M0.93%$193.84$216.12+11.5%
0.9%
OABIOMNIAB INC$5.7M0.92%$4.23$2.42-42.8%
0.9%
CGONCG ONCOLOGY INC$5.4M0.88%$37.73$70.36+86.5%
0.9%
CRNXCRINETICS PHARMACEUTICALS IN$4.5M0.73%$51.10$42.23-17.4%
0.7%
APLTCALLAPPLIED THERAPEUTICS INC$4.5M0.73%β€”β€”
0.7%
HLXBHELIX ACQUISITION CORP II$4.2M0.69%β€”β€”
0.7%

Quarter-on-Quarter Activity

Q3 2024 vs. Q2 2024

New Positions (8)

TickerIssuerNotionalSince Filing
ZURAZURA BIO LTD$15.3M+27.3%
AAMAA MISSION ACQUISITION CORP$10.1M
XNCRXENCOR INC$6.9M-25.4%
SNDXCALLSYNDAX PHARMACEUTICALS INC$6.7M+13.3%
BIIBBIOGEN INC$5.7M+11.5%
XBIPUTSPDR SER TR$4.0M
DNTHDIANTHUS THERAPEUTICS INC$3.3M
GRCEACASTI PHARMA INC$2.9M

Exited Positions (8)

TickerIssuerNotional
QUREUNIQURE NV$5.5M
SPYSPDR S&P 500 ETF TR$4.3M
CERECEREVEL THERAPEUTICS HLDNG I$3.8M
ACSTACASTI PHARMA INC$2.8M
VUSBVANGUARD BD INDEX FDS$2.7M
JPSTJ P MORGAN EXCHANGE TRADED F$2.7M
SHVISHARES TR$2.7M
CERECEREVEL THERAPEUTICS HLDNG I$2.0M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
CYTKCALLCYTOKINETICS INC$48.1M+911082.0%+63.8%
BBIOBRIDGEBIO PHARMA INC$36.9M+120605.8%+203.2%
BBIOBRIDGEBIO PHARMA INC$36.8M+39047.8%+203.2%
RGNXCALLREGENXBIO INC$5.9M+20974.4%+26.6%
APLSAPELLIS PHARMACEUTICALS INC$0.5M+17152.0%
CYTKCALLCYTOKINETICS INC$0.8M+15000.0%+63.8%
SVRASAVARA INC$3.1M+14752.7%
ANABANAPTYSBIO INC$6.4M+12748.0%+184.0%

Trimmed (8)

TickerIssuerNotionalShares Ξ”Since Filing
ACHVACHIEVE LIFE SCIENCES INC$-2.5M-100.0%
KROSCALLKEROS THERAPEUTICS INC$-25.1M-99.9%-80.6%
MRKMERCK & CO INC$-9.3M-98.5%
CYTKCALLCYTOKINETICS INC$-45.5M-98.2%+63.8%
INSMINSMED INC$-13.2M-98.2%
IMVTCALLIMMUNOVANT INC$-12.3M-97.9%+36.1%
INSMINSMED INC$-9.8M-97.6%
APLTAPPLIED THERAPEUTICS INC$-1.4M-97.3%
← Back to Hedge Funds